(DBXU) Xtrackers MSCI USA Swap - Ratings and Ratios
Exposure, Equity, Swap-Based, Large-Cap, Blend
Description: DBXU Xtrackers MSCI USA Swap
The Xtrackers MSCI USA Swap UCITS ETF is an exchange-traded fund that tracks the Morningstar US Large-Mid NR USD index, providing investors with exposure to a broad range of large- and mid-cap US stocks. With its origins in Germany, this ETF is designed to offer a diversified portfolio, leveraging the liquidity and stability of the US equity market.
From a technical standpoint, the ETFs price action indicates a relatively stable trend, with the short-term Simple Moving Average (SMA20) at 155.42 and the medium-term SMA50 at 148.96, suggesting a potential upward momentum as the current price of 156.48 is above both SMAs. However, the long-term SMA200 at 158.64 may pose a resistance level. The Average True Range (ATR) of 2.17, or 1.39%, indicates moderate volatility. The 52-week high and low of 174.65 and 133.25, respectively, provide context for the ETFs recent price movements, indicating a potential for further growth given its current price is above the midpoint of this range.
Fundamentally, the ETF boasts a substantial Assets Under Management (AUM) of 4097.12M EUR, underscoring its popularity and liquidity among investors. This significant AUM also implies that the ETF is well-established and has the capacity to absorb large trades without significantly impacting its price.
Forecasting the ETFs future performance involves analyzing both technical and fundamental data. Given the current price is above its SMA20 and SMA50, and considering the moderate volatility indicated by the ATR, theres a potential for the ETF to continue its upward trend, albeit with potential resistance around the SMA200 level. The strong AUM and the diversified nature of the tracked index suggest a stable foundation for the ETF. Therefore, a potential forecast could be that the ETF may continue to grow, potentially reaching towards its 52-week high, provided that the underlying index continues to perform well and theres no significant downturn in the US large- and mid-cap equity market.
Its also worth noting that the MSCI USA index is a widely followed benchmark for US equity performance, and the ETFs tracking of this index via a swap-based replication method allows it to provide investors with a cost-effective and efficient way to gain exposure to the US market. The UCITS compliance also ensures that the ETF adheres to strict regulatory standards, enhancing its appeal to a broad range of investors.
Additional Sources for DBXU ETF
DBXU ETF Overview
Market Cap in USD | 4,834m |
Category | US Large-Cap Blend Equity |
TER | 0.15% |
IPO / Inception | 2007-01-08 |
DBXU ETF Ratings
Growth Rating | 67.5 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -7.52 |
Analysts | - |
Fair Price Momentum | 152.73 EUR |
Fair Price DCF | - |
DBXU Dividends
Currently no dividends paidDBXU Growth Ratios
Growth Correlation 3m | 77.2% |
Growth Correlation 12m | 20.6% |
Growth Correlation 5y | 90.4% |
CAGR 5y | 14.76% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 0.46 |
Alpha | -7.24 |
Beta | 0.808 |
Volatility | 10.01% |
Current Volume | 1.7k |
Average Volume 20d | 2.2k |
As of July 04, 2025, the stock is trading at EUR 158.94 with a total of 1,713 shares traded.
Over the past week, the price has changed by +1.97%, over one month by +1.96%, over three months by +9.09% and over the past year by +6.18%.
Yes. Based on ValueRay's Analyses, Xtrackers MSCI USA Swap (XETRA:DBXU) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.46 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBXU is around 152.73 EUR . This means that DBXU is currently overvalued and has a potential downside of -3.91%.
Xtrackers MSCI USA Swap has no consensus analysts rating.
According to our own proprietary Forecast Model, DBXU Xtrackers MSCI USA Swap will be worth about 176.5 in July 2026. The stock is currently trading at 158.94. This means that the stock has a potential upside of +11.05%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 176.5 | 11.1% |